Professor of Surgery, UCLA
General Surgery
Dr. Helena R. Chang, MD
|
|
Give Review
Helena Chang works in the field of General Surgery. She studied medicine at Temple University School of Medicine. She received awards:"Fellow (FACS)" and "Super Doctor". Helena Chang has written publications. She has 17 publications published with PubMed. The lastest paper is: 'Combined phosphoproteomics and bioinformatics strategy in deciphering drug resistant related pathways in triple negative breast cancer.'
Publications
- Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer?
- The metabolite α-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR.
- Higher levels of GATA3 predict better survival in women with breast cancer.
- Differential response of triple-negative breast cancer to a docetaxel and carboplatin-based neoadjuvant treatment.
- Hydrophobic Proteome Analysis of Triple Negative and Hormone-Receptor-Positive-Her2-Negative Breast Cancer by Mass Spectrometer.
- Heterotopic breast tissue versus occult metastatic carcinoma in lymph node, a diagnostic dilemma.
- Trastuzumab-based neoadjuvant therapy in patients with HER2-positive breast cancer.
- Hydrophobic Fractionation Enhances Novel Protein Detection by Mass Spectrometry in Triple Negative Breast Cancer.
- Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers.
- Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapy.
- Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis.
- Histopathologic characteristics predicting HER-2/neu amplification in breast cancer.
- Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses.
- Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.
- Development and preclinical evaluation of a Bacillus Calmette-Guérin-MUC1-based novel breast cancer vaccine.
- Combined phosphoproteomics and bioinformatics strategy in deciphering drug resistant related pathways in triple negative breast cancer.
Schools
Temple University School Of Medicine
Episcopal Hospital
Meml Sloan Kettering Cancer
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- Fellow (FACS)
- Super Doctor
Education
-
Memorial Sloan-Kettering Cancer Center -
Temple University School of Medicine
Hospital
-
UCSF Medical Center -
Ronald Reagan UCLA Medical Center
Drug Facts
| NPI NUMBER | 1306859038 | |
| NPPES Provider LastName | CHANG | |
| NPPES Provider FirstName | HELENA | |
| NPPES Provider ZIPCode | 900950001 | |
| NPPES Provider State | CA | |
| Specialty Description | Surgical Oncology | |
| Total Claim Count | 107.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 32.0 | |
| Percent Opioid Claims | 29.91 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1306859038 |
| Last Name Of The Provider | CHANG |
| First Name Of The Provider | HELENA |
| View All |
Similar Doctors
|
Dr. Jennifer N. Keagle, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy Miller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Grace H. Jeon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohd R. Sheikh, MD |
|
|
Dr. Dilipkumar Parekh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Judith M. Laub, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric J. Culbertson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Phyllis D. Paul, MD |
|
|
Dr. Saloomeh Saati, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Seena Safavy, MD |
|
|
Dr. Kirsten L. Thompson, MD |